Director of Translational Hematology & Coagulation

Incyte; Wilmington (DE); On-site; USD 180,000 - 250,000; Full time

Job summary

Incyte, a global biopharmaceutical company headquartered in Wilmington, Delaware, seeks a Director of Translational Sciences to lead hematology and blood coagulation programs. You will shape biomarker strategies and translational research for a novel congenital bleeding disorder therapy, collaborating with industry and academic partners to move from preclinical biology to first-in-human trials.

Ideal candidates balance deep scientific expertise with leadership, delivering clear study designs,

Qualifications

• Advanced degree with strong track record in science.
• Excellent scientific communication and leadership.
• Experience in translational sciences and biomarker strategies.
• Ability to work with internal and external partners.

Responsibilities

• Lead translational strategy for hematology/coagulation programs from discovery through proof-of-concept and beyond.
• Design and oversee biomarker strategies related to coagulation biology and bleeding risk.
• Provide data review, analysis, and documentation to inform clinical decisions.
• Collaborate with clinical partners to translate findings into trial designs.
• Provide input on companion diagnostics where relevant.
• Represent translational science in regulatory interactions (IND/CTA).
• Mentor and lead scientists across Translational Sciences.
• Author and review key scientific documents and publications.

Skills

Verbal communication

Written communication

Emotional intelligence

Collaborative mindset

Scientific curiosity

Program leadership

Biology background

Education

MD/PhD or equivalent

Job description

Incyte, a global biopharmaceutical company headquartered in Wilmington, Delaware, seeks a Director of Translational Sciences to lead hematology and blood coagulation programs. You will shape biomarker strategies and translational research for a novel congenital bleeding disorder therapy, collaborating with industry and academic partners to move from preclinical biology to first-in-human trials.

Ideal candidates balance deep scientific expertise with leadership, delivering clear study designs,